These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 28610981)
1. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors. Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981 [TBL] [Abstract][Full Text] [Related]
2. QSAR Modeling, Molecular Docking and Molecular Dynamics Simulations Studies of Lysine-Specific Demethylase 1 (LSD1) Inhibitors as Anticancer Agents. Abdizadeh R; Heidarian E; Hadizadeh F; Abdizadeh T Anticancer Agents Med Chem; 2021; 21(8):987-1018. PubMed ID: 32698753 [TBL] [Abstract][Full Text] [Related]
3. Probing the binding mechanism of substituted pyridine derivatives as effective and selective lysine-specific demethylase 1 inhibitors using 3D-QSAR, molecular docking and molecular dynamics simulations. Wang ZZ; Yang J; Sun XD; Ma CY; Gao QB; Ding L; Liu HM J Biomol Struct Dyn; 2019 Aug; 37(13):3482-3495. PubMed ID: 30175693 [TBL] [Abstract][Full Text] [Related]
4. Investigating the Binding Mode of Reversible LSD1 Inhibitors Derived from Stilbene Derivatives by 3D-QSAR, Molecular Docking, and Molecular Dynamics Simulation. Xu Y; He Z; Yang M; Gao Y; Jin L; Wang M; Zheng Y; Lu X; Zhang S; Wang C; Zhao Z; Zhao J; Gao Q; Duan Y Molecules; 2019 Dec; 24(24):. PubMed ID: 31817721 [TBL] [Abstract][Full Text] [Related]
5. Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations. Zhao J; Zang J; Yang J; Gao QB; Yan Y; Ma C; Chen Y; Ding L; Liu HM J Biomol Struct Dyn; 2022 Apr; 40(6):2674-2688. PubMed ID: 33183176 [TBL] [Abstract][Full Text] [Related]
6. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations. Xu C; Ren Y Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829 [TBL] [Abstract][Full Text] [Related]
7. Insight into the interaction mechanism of human SGLT2 with its inhibitors: 3D-QSAR studies, homology modeling, and molecular docking and molecular dynamics simulations. Dong L; Feng R; Bi J; Shen S; Lu H; Zhang J J Mol Model; 2018 Mar; 24(4):86. PubMed ID: 29511885 [TBL] [Abstract][Full Text] [Related]
8. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking. Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909 [TBL] [Abstract][Full Text] [Related]
9. Application of 3D-QSAR, Pharmacophore, and Molecular Docking in the Molecular Design of Diarylpyrimidine Derivatives as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors. Liu G; Wang W; Wan Y; Ju X; Gu S Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29751616 [TBL] [Abstract][Full Text] [Related]
10. 3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors. Chaube U; Bhatt H Mol Divers; 2017 Aug; 21(3):741-759. PubMed ID: 28577112 [TBL] [Abstract][Full Text] [Related]
12. Insight into the binding mode of a novel LSD1 inhibitor by molecular docking and molecular dynamics simulations. Zhang X; Li M; Wang Y; Zhao Y J Recept Signal Transduct Res; 2015; 35(5):363-9. PubMed ID: 26364657 [TBL] [Abstract][Full Text] [Related]
13. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking. Zeng H; Zhang H; Jang F; Zhao L; Zhang J Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709 [TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR and molecular docking studies of 2-pyrimidinecarbonitrile derivatives as inhibitors against falcipain-3. Potshangbam AM; Tanneeru K; Reddy BM; Guruprasad L Bioorg Med Chem Lett; 2011 Dec; 21(23):7219-23. PubMed ID: 22018459 [TBL] [Abstract][Full Text] [Related]
15. Molecular docking, 3D-QSAR, and molecular dynamics simulations of thieno[3,2-b]pyrrole derivatives against anticancer targets of KDM1A/LSD1. Zhang X; Yan J; Wang H; Wang Y; Wang J; Zhao D J Biomol Struct Dyn; 2021 Mar; 39(4):1189-1202. PubMed ID: 32036765 [TBL] [Abstract][Full Text] [Related]
16. Design Two Novel Tetrahydroquinoline Derivatives against Anticancer Target LSD1 with 3D-QSAR Model and Molecular Simulation. Xu Y; Fan B; Gao Y; Chen Y; Han D; Lu J; Liu T; Gao Q; Zhang JZ; Wang M Molecules; 2022 Nov; 27(23):. PubMed ID: 36500451 [TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR, molecular docking, and molecular dynamic simulations for prediction of new Hsp90 inhibitors based on isoxazole scaffold. Abbasi M; Sadeghi-Aliabadi H; Amanlou M J Biomol Struct Dyn; 2018 May; 36(6):1463-1478. PubMed ID: 28482755 [TBL] [Abstract][Full Text] [Related]
18. In silico approaches to develop new phenyl-pyrimidines as glycogen synthase kinase 3 (GSK-3) inhibitors with halogen-bonding capabilities: 3D-QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies. Cabezas D; Mellado G; Espinoza N; Gárate JA; Morales C; Castro-Alvarez A; Matos MJ; Mellado M; Mella J J Biomol Struct Dyn; 2023; 41(22):13250-13259. PubMed ID: 36718094 [TBL] [Abstract][Full Text] [Related]
19. In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation. He Q; Han C; Li G; Guo H; Wang Y; Hu Y; Lin Z; Wang Y Comput Biol Chem; 2020 Oct; 88():107328. PubMed ID: 32688011 [TBL] [Abstract][Full Text] [Related]
20. Rational design of methicillin resistance staphylococcus aureus inhibitors through 3D-QSAR, molecular docking and molecular dynamics simulations. Ballu S; Itteboina R; Sivan SK; Manga V Comput Biol Chem; 2018 Apr; 73():95-104. PubMed ID: 29475176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]